Publication at First Faculty of Medicine |
2010
Abstract
GRACE 02 study evaluated bio-availability, safety and efficacy of antibiotic rifaximin administered in a form of gastro-resistant granules in two dosage regimes (800mg vs. 1600mg daily) to patients with moderate to severe active Crohn´s disease.